阿伐那非生物电子等排衍生物的合成及其对磷酸二酯酶Ⅴ型抑制活性研究

    Synthesis and Study on the Phosphodiesterase Type 5 Inhibitory Activity of Bioisosteric Derivatives of Avanafil

    • 摘要:
      目的  设计合成新型阿伐那非衍生物,并考察其对磷酸二酯酶Ⅴ型(phosphodiesterase type 5,PDE5)的抑制活性。
      方法 以阿伐那非为先导化合物,利用生物电子等排原理设计合成了20个阿伐那非衍生物,通过基于荧光偏振技术的PDE5酶活性测试,对衍生物的体外PDE5抑制活性进行定量筛选。
      结果 硫代酰胺衍生物Ⅰ-2Ⅰ-4Ⅰ-5Ⅰ-7的PDE5抑制活性相对较好,但仍低于阿伐那非;氯代衍生物Ⅱ-1Ⅱ-6的PDE5抑制活性较为突出,其IC50值与阿伐那非相当。
      结论 氯代衍生物Ⅱ-1的PDE5抑制活性最好,值得进一步深入研究;构效关系分析为基于阿伐那非的PDE5抑制剂的结构优化提供了有益参考,为新型勃起功能障碍治疗药物的研发奠定了基础。

       

      Abstract:
      OBJECTIVE To design and synthesize novel avanafil derivatives and investigate their inhibitory activity on phosphodiesterase type 5(PDE5).
      METHODS Using avanafil as a lead compound, 20 avanafil derivatives were designed and synthesized based on the bioisosterism principle. The in vitro inhibitory activity of these derivatives on PDE5 was quantitatively screened using a fluorescence polarization-based PDE5 enzyme activity assay.
      RESULTS Among the derivatives, thioamide derivatives Ⅰ-2, Ⅰ-4,Ⅰ-5, and Ⅰ-7 demonstrated relatively good PDE5 inhibitory activity, though still lower than avanafil. The chloro derivatives Ⅱ-1 and Ⅱ-6 showed notably strong PDE5 inhibitory activity, with IC50 values comparable to avanafil.
      CONCLUSION Chloro derivative Ⅱ-1 exhibited the best PDE5 inhibitory activity, meriting further in-depth study. The structure-activity relationship analysis provides valuable insights for structural optimization of PDE5 inhibitors based on avanafil, laying a foundation for the development of novel erectile dysfunction therapeutics.

       

    /

    返回文章
    返回